It is a prime concern of Evotec that all relevant target groups receive the same information at the same time. This implies communicating in both English and German.

Please find below the most recent corporate news, ad hoc releases and other announcements of our Company.

 

2017

Read our article on Form Selection Problems in the Pharmaceutical Field
Nerina Coppini, 14 July 2017

Our Material Sciences and API experts Matteo Daldosso, Zadeo Cimarosti and Brigida Allieri have recently published an article where they discuss about the "form selection problem in the pharmaceutical field" and the importance of X-Rays Powder Diffraction technique to respond to the implications and challenges related to the API polymorphism. ...

Aptuit Selected as a Winner of Life Science Leader Global Award for Contract Drug Manufacturer in Multiple Categories
Nerina Coppini, 13 March 2017

Greenwich, CT – March 13, 2017 - Aptuit, LLC today announced that the company has been selected as a winner of four Contract Manufacturer Organization (CMO) Leadership Awards by Life Science Leader magazine. Aptuit was selected from a survey of pharma and biopharma companies who had outsourced projects within the past 18 months. Customers judge...

 

Other announcements

Merger

The following annoucement has been published in the German Federal Gazette in accordance with the German Conversion Act (Umwandlungsgesetz) in 2013. Pursuant to the German Conversion Act, certain transaction intended by Evotec AG, e.g. up-stream mergers, have to be announced in the Federal Gazette (Bundesanzeiger).

Contact us

Gabriele Hansen

VP, Corporate Communications & Investor Relations

T +49 40 560 81 255 F +49 40 560 81 333 vCard

Katja Werner

Investor Relations Associate

T +49 40 560 81 210 F +49 40 560 81 333 vCard